BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol. 2013;2013:623036. [PMID: 24027590 DOI: 10.1155/2013/623036] [Cited by in Crossref: 123] [Cited by in F6Publishing: 116] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Altini C, Ruta R, Mammucci P, Rubini D, Ferrari C, Sardaro A, Pisani AR. Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00497-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Afzelius P, Morsing MK, Nielsen OL, Alstrup AKO, Jensen SB, Jødal L. Lymph Nodes Draining Infections Investigated by PET and Immunohistochemistry in a Juvenile Porcine Model. Molecules 2022;27:2792. [PMID: 35566137 DOI: 10.3390/molecules27092792] [Reference Citation Analysis]
3 Piri R, Nøddeskou-Fink AH, Gerke O, Larsson M, Edenbrandt L, Enqvist O, Høilund-Carlsen PF, Stochkendahl MJ. PET/CT imaging of spinal inflammation and microcalcification in patients with low back pain: A pilot study on the quantification by artificial intelligence-based segmentation. Clin Physiol Funct Imaging 2022. [PMID: 35319166 DOI: 10.1111/cpf.12751] [Reference Citation Analysis]
4 Hajishengallis G, Li X, Divaris K, Chavakis T. Maladaptive trained immunity and clonal hematopoiesis as potential mechanistic links between periodontitis and inflammatory comorbidities. Periodontol 2000 2022. [PMID: 35244943 DOI: 10.1111/prd.12421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Anan N, Zainon R, Tamal M. A review on advances in 18F-FDG PET/CT radiomics standardisation and application in lung disease management. Insights Imaging 2022;13. [DOI: 10.1186/s13244-021-01153-9] [Reference Citation Analysis]
6 Chen BX, Xie B, Zhou Y, Shi L, Wang Y, Zeng L, Liu X, Yang MF. Association of Serum Biomarkers and Cardiac Inflammation in Patients With Atrial Fibrillation: Identification by Positron Emission Tomography. Front Cardiovasc Med 2021;8:735082. [PMID: 34712708 DOI: 10.3389/fcvm.2021.735082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hayashi D, Gould E, Shroyer R, van Staalduinen E, Yang J, Mufti M, Huang M. Shoulder adhesive capsulitis in cancer patients undergoing positron emission tomography - computed tomography and the association with shoulder pain. World J Radiol 2021; 13(10): 344-353 [PMID: 34786189 DOI: 10.4329/wjr.v13.i10.344] [Reference Citation Analysis]
8 Liu Y, Xie ZZ, Wang X, Zhu ZH, Yang C. Clinical study of invasive pulmonary aspergillosis following influenza A H1N1. Medicine (Baltimore) 2021;100:e26434. [PMID: 34397685 DOI: 10.1097/MD.0000000000026434] [Reference Citation Analysis]
9 Gonzalez-Cantero A, Teklu M, Sorokin AV, Prussick R, González-Cantero J, Martin-Rodriguez JL, Patel N, Parel PM, Manyak GA, Teague HL, Rodante JA, Keel A, Pérez-Hortet C, Sanchéz-Moya AI, Jiménez N, Ballester A, Solis J, Fernandez-Friera L, Barderas MG, Gonzalez-Calvin JL, Jaen P, Playford MP, Dey AK, Gelfand JM, Mehta NN. Subclinical Liver Disease is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies. J Invest Dermatol 2021:S0022-202X(21)01461-5. [PMID: 34293354 DOI: 10.1016/j.jid.2021.05.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D'Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021;9:299-339. [PMID: 34277510 DOI: 10.1007/s40336-021-00445-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
11 Ho TC, Chang CC, Chan HP, Huang YF, Chen YA, Chuang KP, Lee CH, Yuan CH, Deng YZ, Yang MH, Tyan YC. Pulmonary Findings of [18F]FDG PET/CT Images on Asymptomatic COVID-19 Patients. Pathogens 2021;10:839. [PMID: 34357989 DOI: 10.3390/pathogens10070839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Giovannini I, Zabotti A, Cicciò C, Salgarello M, Cereser L, De Vita S, Tinazzi I. Axial Psoriatic Disease: Clinical and Imaging Assessment of an Underdiagnosed Condition. J Clin Med 2021;10:2845. [PMID: 34199051 DOI: 10.3390/jcm10132845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Salah H, Al-Mohammed HI, Mayhoub FH, Sulieman A, Alkhorayef M, Abolaban FA, Khandaker MU, Bradley DA. Assessment of Patient's Radiation Exposures Resulted from PET/CT 18F-FCH and 68GA-PSMA Procedures. Radiat Prot Dosimetry 2021:ncab077. [PMID: 34144608 DOI: 10.1093/rpd/ncab077] [Reference Citation Analysis]
14 Mondal T, Nautiyal A, Ghosh S, Loffredo CA, Mitra D, Saha C, Dey SK. An evaluation of DNA double strand break formation and excreted guanine species post whole body PET/CT procedure. J Radiat Res 2021;62:590-9. [PMID: 34037214 DOI: 10.1093/jrr/rrab025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ankrah AO, Sathekge MM, Dierckx RAJO, Glaudemans AWJM. Radionuclide Imaging of Fungal Infections and Correlation with the Host Defense Response. J Fungi (Basel) 2021;7:407. [PMID: 34067410 DOI: 10.3390/jof7060407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Mahajna H, Vaknin K, Ben Shimol J, Watad A, Abu-Much A, Mahroum N, Shovman O, Shoenfeld Y, Amital H, Davidson T. The Utility of 18FDG-PET/CT in Diagnosing Fever of Unknown Origin: The Experience of a Large Tertiary Medical Center. Int J Environ Res Public Health 2021;18:5360. [PMID: 34069883 DOI: 10.3390/ijerph18105360] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Bauckneht M, Raffa S, Leale G, Sambuceti V, De Cesari M, Donegani MI, Marini C, Drakonaki E, Orlandi D. Molecular imaging in MSK radiology: Where are we going? Eur J Radiol 2021;140:109737. [PMID: 33951567 DOI: 10.1016/j.ejrad.2021.109737] [Reference Citation Analysis]
18 van der Krogt JMA, van Binsbergen WH, van der Laken CJ, Tas SW. Novel positron emission tomography tracers for imaging of rheumatoid arthritis. Autoimmun Rev 2021;20:102764. [PMID: 33476822 DOI: 10.1016/j.autrev.2021.102764] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Ankrah AO, Creemers-Schild D, de Keizer B, Klein HC, Dierckx RAJO, Kwee TC, Span LFR, de Jong PA, Sathekge MM, Glaudemans AWJM. The Added Value of [18F]FDG PET/CT in the Management of Invasive Fungal Infections. Diagnostics (Basel) 2021;11:137. [PMID: 33477267 DOI: 10.3390/diagnostics11010137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Wang J, van Dam RM. High-Efficiency Production of Radiopharmaceuticals via Droplet Radiochemistry: A Review of Recent Progress. Mol Imaging 2020;19:1536012120973099. [PMID: 33296272 DOI: 10.1177/1536012120973099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
21 Le Fur M, Zhou IY, Catalano O, Caravan P. Toward Molecular Imaging of Intestinal Pathology. Inflamm Bowel Dis 2020;26:1470-84. [PMID: 32793946 DOI: 10.1093/ibd/izaa213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Salah H, Mayhoub FH, Sulieman A, Abuzaid M, Al-mohammed H, Alkhorayef M, Bradley D. Fluoro-D-glucose (18F-FDG) PET/CT and patient effective dose. Radiation Physics and Chemistry 2020;173:108926. [DOI: 10.1016/j.radphyschem.2020.108926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Georga S, Exadaktylou P, Petrou I, Katsampoukas D, Mpalaris V, Moralidis EI, Arvaniti K, Papastergiou C, Arsos G. Diagnostic Value of 18F-FDG-PET/CT in Patients with FUO. J Clin Med 2020;9:E2112. [PMID: 32635566 DOI: 10.3390/jcm9072112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
24 Mahmutovic Persson I, Falk Håkansson H, Örbom A, Liu J, von Wachenfeldt K, Olsson LE. Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin. Front Physiol 2020;11:584. [PMID: 32636756 DOI: 10.3389/fphys.2020.00584] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kong Z, Wang Y, Ma W, Cheng X. Role of 18F-fluorodeoxyglucose (FDG) and 18F-2-fluorodeoxy sorbitol (FDS) in autoimmune hypophysitis: a case report. BMC Endocr Disord 2020;20:84. [PMID: 32517690 DOI: 10.1186/s12902-020-00567-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 McCarthy CE, White JM, Viola NT, Gibson HM. In vivo Imaging Technologies to Monitor the Immune System. Front Immunol 2020;11:1067. [PMID: 32582173 DOI: 10.3389/fimmu.2020.01067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
27 MacRitchie N, Frleta-Gilchrist M, Sugiyama A, Lawton T, McInnes IB, Maffia P. Molecular imaging of inflammation - Current and emerging technologies for diagnosis and treatment. Pharmacol Ther 2020;211:107550. [PMID: 32325067 DOI: 10.1016/j.pharmthera.2020.107550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
28 Wang L, Xiong C, Li M, Zeng X, Wang Q, Fang W, Zhao L. Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study. Ann Nucl Med 2020;34:407-14. [PMID: 32314147 DOI: 10.1007/s12149-020-01461-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Giraudo C, Evangelista L, Fraia AS, Lupi A, Quaia E, Cecchin D, Casali M. Molecular Imaging of Pulmonary Inflammation and Infection. Int J Mol Sci 2020;21:E894. [PMID: 32019142 DOI: 10.3390/ijms21030894] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
30 Treglia G, Slart RHJA, Glaudemans AWJM. Diagnostic performance and image interpretation of 18F-FDG PET/CT in aortic graft infection: Two sides of the same coin. J Nucl Cardiol . [DOI: 10.1007/s12350-020-02029-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Ørbæk M, Klausen C, Lebech AM, Mens H. Lyme Neuroborreliosis in a Patient with Breast Cancer: MRI and PET/CT Findings. Diagnostics (Basel) 2020;10:E36. [PMID: 31936608 DOI: 10.3390/diagnostics10010036] [Reference Citation Analysis]
32 Kersey CB, Flaherty KR, Goldenthal IL, Bokhari S, Biviano AB. The use of serial cardiac 18F-fluorodeoxyglucose- positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and review. Eur Heart J Case Rep 2019;3:1-7. [PMID: 32123792 DOI: 10.1093/ehjcr/ytz188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Stanzani M, Sassi C, Battista G, Lewis RE. Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease. Med Mycol 2019;57:S274-86. [PMID: 31292659 DOI: 10.1093/mmy/myy125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Treglia G. Diagnostic Performance of 18F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses. Contrast Media Mol Imaging. 2019;2019:3018349. [PMID: 31427907 DOI: 10.1155/2019/3018349] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
35 Furuya MY, Temmoku J, Fujita Y, Matsuoka N, Asano T, Sato S, Kobayashi H, Watanabe H, Migita K. Vasculo-Behçet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT). Fukushima J Med Sci 2019;65:55-60. [PMID: 31327803 DOI: 10.5387/fms.2019-07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Signore A, Lauri C, Auletta S, Anzola K, Galli F, Casali M, Versari A, Glaudemans AWJM. Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology. J Clin Med 2019;8:E681. [PMID: 31091813 DOI: 10.3390/jcm8050681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
37 Raynal M, Bouderraoui F, Ouichka R, Melchior J, Morel O, Blum A, Chary-Valckenaere I, Ngueyon Sime W, Roch V, Maksymowych W, Lambert RG, Olivier P, Loeuille D. Performance of 18F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging and computed tomography, respectively, in axial spondyloarthritis. Arthritis Res Ther 2019;21:119. [PMID: 31088514 DOI: 10.1186/s13075-019-1903-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
38 Małkowski B, Serafin Z, Glonek R, Suwała S, Łopatto R, Junik R. The Role of 18F-FDG PET/CT in the Management of the Autoimmune Thyroid Diseases. Front Endocrinol (Lausanne) 2019;10:208. [PMID: 31024448 DOI: 10.3389/fendo.2019.00208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Giannakis N, Sansbury BE, Patsalos A, Hays TT, Riley CO, Han X, Spite M, Nagy L. Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration. Nat Immunol 2019;20:626-36. [PMID: 30936495 DOI: 10.1038/s41590-019-0356-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 68] [Article Influence: 15.7] [Reference Citation Analysis]
40 Cao Q, Huang Q, Mohan C, Li C. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using 64Cu-αCD11b. J Nucl Med 2019;60:1317-24. [PMID: 30796172 DOI: 10.2967/jnumed.118.220350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
41 Di Mango AL, Zanetti G, Penha D, Menna Barreto M, Marchiori E. Endemic pulmonary fungal diseases in immunocompetent patients: an emphasis on thoracic imaging. Expert Rev Respir Med 2019;13:263-77. [PMID: 30668231 DOI: 10.1080/17476348.2019.1571914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
42 Khanna NN, Jamthikar AD, Gupta D, Piga M, Saba L, Carcassi C, Giannopoulos AA, Nicolaides A, Laird JR, Suri HS, Mavrogeni S, Protogerou AD, Sfikakis P, Kitas GD, Suri JS. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization. Curr Atheroscler Rep 2019;21:7. [PMID: 30684090 DOI: 10.1007/s11883-019-0766-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
43 Ozmen O, Tatci E, Uslu Biner I, Findik G, Yilmaz U, Erturk H, Demirag F. Could SUVmax be an auxiliary parameter in the clinical management of pulmonary hydatid disease? Clin Respir J 2019;13:58-65. [PMID: 30556309 DOI: 10.1111/crj.12981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Stern Shavit S, Bernstine H, Sopov V, Nageris B, Hilly O. FDG-PET/CT for diagnosis and follow-up of necrotizing (malignant) external otitis. Laryngoscope 2019;129:961-6. [PMID: 30549258 DOI: 10.1002/lary.27526] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
45 Dowdell J, Brochin R, Kim J, Overley S, Oren J, Freedman B, Cho S. Postoperative Spine Infection: Diagnosis and Management. Global Spine J 2018;8:37S-43S. [PMID: 30574436 DOI: 10.1177/2192568217745512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
46 Davda S, Kowa X, Aziz Z, Ellis S, Cheasty E, Cappocci S, Balan A. The development of pulmonary aspergillosis and its histologic, clinical, and radiologic manifestations. Clinical Radiology 2018;73:913-21. [DOI: 10.1016/j.crad.2018.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
47 Salmanoglu E, Kim S, Thakur ML. Currently Available Radiopharmaceuticals for Imaging Infection and the Holy Grail. Semin Nucl Med 2018;48:86-99. [PMID: 29452623 DOI: 10.1053/j.semnuclmed.2017.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
48 Cussó L, Desco M. Suppression of 18F-FDG signal in the bladder on small animal PET-CT. PLoS One 2018;13:e0205610. [PMID: 30332442 DOI: 10.1371/journal.pone.0205610] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Schirmer MR, Carneiro MP, Machado LS, Chaves ALDS, Lopes FPPL. Fluorine-18-fluorodeoxyglucose PET/CT in hematopoietic stem cell transplant patients with fusariosis: initial findings of a case series review. Nucl Med Commun 2018;39:545-52. [PMID: 29652746 DOI: 10.1097/MNM.0000000000000834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kim J, Song HC. Role of PET/CT in the Evaluation of Aortic Disease. Chonnam Med J 2018;54:143-52. [PMID: 30288369 DOI: 10.4068/cmj.2018.54.3.143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
51 Mabey E, Rutherford A, Galloway J. Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET/CT Scans and Novel Biomarkers Hold The Answer? Curr Rheumatol Rep 2018;20:70. [PMID: 30225546 DOI: 10.1007/s11926-018-0779-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Kimura H, Yamauchi S, Kawashima H, Arimitsu K, Yagi Y, Nakamoto Y, Togashi K, Ono M, Saji H. Synthesis and evaluation of a [18F]formyl-Met-Leu-Phe derivative: A positron emission tomography imaging probe for bacterial infections. Bioorg Med Chem Lett 2018;28:2949-52. [PMID: 30006064 DOI: 10.1016/j.bmcl.2018.07.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Akaike G, Itani M, Shah H, Ahuja J, Yilmaz Gunes B, Assaker R, Behnia F. PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations. RadioGraphics 2018;38:1536-49. [DOI: 10.1148/rg.2018180053] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
54 Mitra A, Pencharz D, Davis M, Wagner T. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection. Ann Vasc Surg 2018;53:78-85. [PMID: 30012456 DOI: 10.1016/j.avsg.2018.04.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
55 Perel-Winkler A, Bokhari S, Perez-Recio T, Zartoshti A, Askanase A, Geraldino-Pardilla L. Myocarditis in systemic lupus erythematosus diagnosed by 18F-fluorodeoxyglucose positron emission tomography. Lupus Sci Med 2018;5:e000265. [PMID: 30094040 DOI: 10.1136/lupus-2018-000265] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
56 Chao PH, Lazari M, Hanet S, Narayanam MK, Murphy JM, van Dam RM. Automated concentration of [18F]fluoride into microliter volumes. Appl Radiat Isot 2018;141:138-48. [PMID: 30243135 DOI: 10.1016/j.apradiso.2018.06.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
57 Douglas A, Lau E, Thursky K, Slavin M. What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer. Curr Opin Infect Dis 2017;30:552-64. [PMID: 28922285 DOI: 10.1097/QCO.0000000000000405] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
58 Verberne SJ, Temmerman OPP, Vuong BH, Raijmakers PG. Fluorodeoxyglucose positron emission tomography imaging for diagnosing periprosthetic hip infection: the importance of diagnostic criteria. International Orthopaedics (SICOT) 2018;42:2025-34. [DOI: 10.1007/s00264-018-3931-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
59 Menendez MI, Hettlich B, Wei L, Knopp MV. Preclinical Multimodal Molecular Imaging Using 18F-FDG PET/CT and MRI in a Phase I Study of a Knee Osteoarthritis in In Vivo Canine Model. Mol Imaging 2017;16:1536012117697443. [PMID: 28654381 DOI: 10.1177/1536012117697443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
60 Burke CJ, Walter WR, Adler RS, Babb JS, Sanger J, Ponzo F. Ultrasound and PET-CT Correlation in Shoulder Pathology: A 5-Year Retrospective Analysis. Clin Nucl Med 2017;42:e424-30. [PMID: 28759525 DOI: 10.1097/RLU.0000000000001778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Ly J, Ha NS, Cheung S, van Dam RM. Toward miniaturized analysis of chemical identity and purity of radiopharmaceuticals via microchip electrophoresis. Anal Bioanal Chem 2018;410:2423-36. [PMID: 29470664 DOI: 10.1007/s00216-018-0924-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
62 Swart LE, Scholtens AM, Tanis W, Nieman K, Bogers AJJC, Verzijlbergen FJ, Krestin GP, Roos-hesselink JW, Budde RPJ. 18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice. European Heart Journal 2018;39:3739-49. [DOI: 10.1093/eurheartj/ehx784] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
63 Freise AC, Zettlitz KA, Salazar FB, Tavaré R, Tsai WK, Chatziioannou AF, Rozengurt N, Braun J, Wu AM. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis. J Nucl Med 2018;59:980-5. [PMID: 29326360 DOI: 10.2967/jnumed.117.199075] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
64 Jamar F, Versari A, Galli F, Lecouvet F, Signore A. Molecular Imaging of Inflammatory Arthritis and Related Disorders. Semin Nucl Med 2018;48:277-90. [PMID: 29626944 DOI: 10.1053/j.semnuclmed.2017.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
65 Wiehr S, Warnke P, Rolle AM, Schütz M, Oberhettinger P, Kohlhofer U, Quintanilla-Martinez L, Maurer A, Thornton C, Boschetti F, Reischl G, Autenrieth IB, Pichler BJ, Autenrieth SE. New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget 2016;7:10990-1001. [PMID: 26934329 DOI: 10.18632/oncotarget.7770] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
66 Hu L, Pan Y, Zhou Z, Gao J. Application of positron emission tomography-computed tomography in the diagnosis of pulmonary ground-glass nodules. Exp Ther Med 2017;14:5109-13. [PMID: 29201223 DOI: 10.3892/etm.2017.5194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Siitonen R, Pietikäinen A, Liljenbäck H, Käkelä M, Söderström M, Jalkanen S, Hytönen J, Roivainen A. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice. Arthritis Res Ther 2017;19:254. [PMID: 29166944 DOI: 10.1186/s13075-017-1460-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
68 Ha NS, Sadeghi S, van Dam RM. Recent Progress toward Microfluidic Quality Control Testing of Radiopharmaceuticals. Micromachines (Basel) 2017;8:E337. [PMID: 30400527 DOI: 10.3390/mi8110337] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
69 Sachchithanantham S, Hutt DF, Quigley AM, Hawkins P, Wechalekar AD. Role of 99m Tc-DPD scintigraphy in imaging extra-cardiac light chain (AL) amyloidosis. Br J Haematol 2018;183:506-9. [PMID: 29082513 DOI: 10.1111/bjh.14988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
70 Kurtys E, Doorduin J, Eisel UL, Dierckx RA, de Vries EF. Evaluating [11C]PBR28 PET for Monitoring Gut and Brain Inflammation in a Rat Model of Chemically Induced Colitis. Mol Imaging Biol 2017;19:68-76. [PMID: 27402092 DOI: 10.1007/s11307-016-0979-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
71 Ahn SS, Hwang SH, Jung SM, Lee SW, Park YB, Yun M, Song JJ. The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome. Medicine (Baltimore) 2017;96:e7901. [PMID: 28834911 DOI: 10.1097/MD.0000000000007901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
72 Zhao L, Zhu M, Li Y, Xing Y, Zhao J. Radiolabeled Dendrimers for Nuclear Medicine Applications. Molecules 2017;22:E1350. [PMID: 28841180 DOI: 10.3390/molecules22091350] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
73 Patsalos A, Pap A, Varga T, Trencsenyi G, Contreras GA, Garai I, Papp Z, Dezso B, Pintye E, Nagy L. In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury. J Physiol 2017;595:5815-42. [PMID: 28714082 DOI: 10.1113/JP274361] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
74 Rice DD, Abramovitch K, Roche S, Cora CA, Torralba KD, Christensen HL, Christiansen EL. Undiagnosed, chronic temporomandibular joint pain: making a case for FDG-PET/CT. Int J Rheum Dis 2017;20:2122-6. [PMID: 28730618 DOI: 10.1111/1756-185X.13134] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Heuker M, Sijbesma JWA, Aguilar Suárez R, de Jong JR, Boersma HH, Luurtsema G, Elsinga PH, Glaudemans AWJM, van Dam GM, van Dijl JM, Slart RHJA, van Oosten M. In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography. Sci Rep 2017;7:4973. [PMID: 28694519 DOI: 10.1038/s41598-017-05403-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
76 Ertay T, Sencan Eren M, Karaman M, Oktay G, Durak H. 18F-FDG-PET/CT in Initiation and Progression of Inflammation and Infection. Mol Imaging Radionucl Ther 2017;26:47-52. [PMID: 28613196 DOI: 10.4274/mirt.18291] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
77 Alavi A, Werner TJ. FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future. Eur J Nucl Med Mol Imaging 2017;44:417-20. [PMID: 28039496 DOI: 10.1007/s00259-016-3606-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
78 Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017;46:1247-1262. [PMID: 28370695 DOI: 10.1002/jmri.25711] [Cited by in Crossref: 75] [Cited by in F6Publishing: 100] [Article Influence: 15.0] [Reference Citation Analysis]
79 Rehak Z, Sprlakova-Pukova A, Bortlicek Z, Fojtik Z, Kazda T, Joukal M, Koukalova R, Vasina J, Eremiasova J, Nemec P. PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis. Radiol Oncol 2017;51:8-14. [PMID: 28265227 DOI: 10.1515/raon-2017-0001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
80 Gupta M, Datta A, Choudhury PS, Dsouza M, Batra U, Mishra A. Can 18F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with 18F-Fluorodeoxyglucose Positron Emission Tomography? World J Nucl Med 2017;16:133-9. [PMID: 28553180 DOI: 10.4103/1450-1147.203071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
81 Kawanishi H, Ito K, Kamido S, Kohno Y, Uemura T, Kato K, Uetsuki H, Ohno H, Okumura K. Advantage of urological experience with both transperitoneal and retroperitoneal laparoscopy in lymph node biopsy for malignant lymphoma diagnosis. Investig Clin Urol 2016;57:401-7. [PMID: 27847913 DOI: 10.4111/icu.2016.57.6.401] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Rehak Z, Vasina J, Ptacek J, Kazda T, Fojtik Z, Nemec P. PET/CT in giant cell arteritis: High 18F-FDG uptake in the temporal, occipital and vertebral arteries. Rev Esp Med Nucl Imagen Mol 2016;35:398-401. [PMID: 27177856 DOI: 10.1016/j.remn.2016.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
83 Stelzmueller I, Huber H, Wunn R, Hodolic M, Mandl M, Lamprecht B, Schinko H, Fellner F, Skanjeti A, Giammarile F, Colletti PM, Rubello D, Gabriel M. 18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis. Clin Nucl Med 2016;41:e187-94. [PMID: 26704732 DOI: 10.1097/RLU.0000000000001102] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
84 Rehak Z, Vasina J, Ptacek J, Kazda T, Fojtik Z, Nemec P. PET/CT in giant cell arteritis: High 18F-FDG uptake in the temporal, occipital and vertebral arteries. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2016;35:398-401. [DOI: 10.1016/j.remnie.2016.03.008] [Reference Citation Analysis]
85 Caobelli F, Evangelista L, Quartuccio N, Familiari D, Altini C, Castello A, Cucinotta M, Di Dato R, Ferrari C, Kokomani A, Laghai I, Laudicella R, Migliari S, Orsini F, Pignata SA, Popescu C, Puta E, Ricci M, Seghezzi S, Sindoni A, Sollini M, Sturiale L, Svyridenka A, Vergura V, Alongi P, Young AIMN Working Group. Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art. World J Radiol 2016; 8(10): 829-845 [PMID: 27843542 DOI: 10.4329/wjr.v8.i10.829] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
86 Wiehr S, Rolle AM, Warnke P, Kohlhofer U, Quintanilla-Martinez L, Reischl G, Autenrieth IB, Pichler BJ, Autenrieth SE. The Positron Emission Tomography Tracer 3'-Deoxy-3'-[18F]Fluorothymidine ([18F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice. PLoS One 2016;11:e0164163. [PMID: 27701464 DOI: 10.1371/journal.pone.0164163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Meyer Z, Fischer M, Koerfer J, Laser K, Kececioglu D, Burchert W, Ulrich S, Preuss R, Haas N. The role of FDG-PET-CT in pediatric cardiac patients and patients with congenital heart defects. International Journal of Cardiology 2016;220:656-60. [DOI: 10.1016/j.ijcard.2016.06.109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
88 García JR. Febrile syndrome of unknown origin: Indications for 18F-FDG PET/CT in inflammatory and infectious processes. Radiologia 2017;59:253-63. [PMID: 27671947 DOI: 10.1016/j.rx.2016.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Di Gialleonardo V, Wilson DM, Keshari KR. The Potential of Metabolic Imaging. Semin Nucl Med 2016;46:28-39. [PMID: 26687855 DOI: 10.1053/j.semnuclmed.2015.09.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
90 Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, Nassenstein K, Schlosser T. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI. J Nucl Cardiol 2018;25:785-94. [DOI: 10.1007/s12350-016-0616-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 73] [Article Influence: 9.8] [Reference Citation Analysis]
91 Granados U, Fuster D, Pericas JM, Llopis JL, Ninot S, Quintana E, Almela M, Paré C, Tolosana JM, Falces C, Moreno A, Pons F, Lomeña F, Miro JM. Diagnostic Accuracy of 18 F-FDG PET/CT in Infective Endocarditis and Implantable Cardiac Electronic Device Infection: A Cross-Sectional Study. J Nucl Med 2016;57:1726-32. [DOI: 10.2967/jnumed.116.173690] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
92 Castellani M, Vadrucci M, Florimonte L, Caronni M, Benti R, Bonara P. 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis. Ann Nucl Med 2016;30:409-20. [PMID: 27068039 DOI: 10.1007/s12149-016-1075-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
93 Hyafil F, Rouzet F, Le Guludec D. Nuclear imaging for patients with a suspicion of infective endocarditis: Be part of the team! J Nucl Cardiol 2017;24:207-11. [DOI: 10.1007/s12350-015-0369-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
94 Rehak Z, Vasina J, Nemec P, Fojtik Z, Koukalova R, Bortlicek Z, Rehakova D, Adam J, Vavrusova A, Adam Z. Various forms of <sup>18</sup>F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;159:629-36. [DOI: 10.5507/bp.2015.026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
95 Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y, Wang QS. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia. Eur J Radiol 2016;85:205-10. [PMID: 26724667 DOI: 10.1016/j.ejrad.2015.11.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
96 Lei W, Zeng H, Zeng DX, Zhang B, Zhu YH, Jiang JH, Huang JA. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol 2016;89:20150695. [PMID: 26529231 DOI: 10.1259/bjr.20150695] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
97 Glaudemans AW, Israel O, Slart RH. Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation. Seminars in Nuclear Medicine 2015;45:500-12. [DOI: 10.1053/j.semnuclmed.2015.02.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
98 Kosaka N, Tsuchida T, Tsuji K, Shimizu K, Kimura H. Standardized uptake value differences between primary and metastatic lesions in ¹⁸F-FDG PET/CT of patients with lung cancer. Acta Radiol 2015;56:1329-35. [PMID: 25398775 DOI: 10.1177/0284185114556705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
99 Cortés-romera M, Sabaté-llobera A, Gámez-cenzano C, Torras-ambròs J. Utilidad de la PET/TC en la enfermedad por IgG4. Medicina Clínica 2015;145:321-2. [DOI: 10.1016/j.medcli.2014.11.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
100 Karunanithi S, Kumar G, Sharma SK, Jain D, Gupta A, Kumar R. Staging and response of sternal histoplasmosis by 18F-FDG PET/CT. Clin Nucl Med 2015;40:231-3. [PMID: 25188644 DOI: 10.1097/RLU.0000000000000578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
101 Park JH, Lee YK, Kim DH, Kim SJ, Lee JH, Jeon TJ, Ryu YH, Lee JD. Usefulness of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Monitoring Adhesive Capsulitis After Breast Cancer Treatment.J Comput Assist Tomogr. 2015;39:349-355. [PMID: 25700225 DOI: 10.1097/RCT.0000000000000222] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
102 Balink H, Veeger NJ, Bennink RJ, Slart RH, Holleman F, van Eck-smit BL, Verberne HJ. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin. Nuclear Medicine Communications 2015;36:604-9. [DOI: 10.1097/mnm.0000000000000300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
103 Del Sole A, Lecchi M, Lucignani G. Variability of [18F]FDG administered activities among patients undergoing PET examinations: an international multicenter survey. Radiat Prot Dosimetry 2016;168:337-42. [PMID: 25994847 DOI: 10.1093/rpd/ncv345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Husmann L, Sah BR, Scherrer A, Burger IA, Stolzmann P, Weber R, Rancic Z, Mayer D, Hasse B; VASGRA Cohort. ¹⁸F-FDG PET/CT for Therapy Control in Vascular Graft Infections: A First Feasibility Study. J Nucl Med 2015;56:1024-9. [PMID: 25977463 DOI: 10.2967/jnumed.115.156265] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
105 Signore A, Glaudemans AW, Galli F, Rouzet F. Imaging infection and inflammation. Biomed Res Int 2015;2015:615150. [PMID: 25879030 DOI: 10.1155/2015/615150] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
106 Tlili G, Amraoui S, Mesguich C, Rivière A, Bordachar P, Hindié E, Bordenave L. High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients. J Nucl Cardiol 2015;22:787-98. [PMID: 25788402 DOI: 10.1007/s12350-015-0067-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
107 Zhuang H, Codreanu I. Growing applications of FDG PET-CT imaging in non-oncologic conditions. J Biomed Res 2015;29:189-202. [PMID: 26060443 DOI: 10.7555/JBR.29.20140081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
108 Li J, Gerlach RL, Jonsson CB, Gray BD, Pak KY, Ng CK. Characterization of 18F-dipicolylamine (DPA) derivatives in cells infected with influenza virus. Nuclear Medicine and Biology 2015;42:283-91. [DOI: 10.1016/j.nucmedbio.2014.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
109 Dong M, Wang C, Zhao K, Wang G, Sun M, Liu Z, Xu L. 18F-FDG PET/CT in patients with adult-onset Still’s disease. Clin Rheumatol 2015;34:2047-56. [DOI: 10.1007/s10067-015-2901-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
110 Balink H, Tan SS, Veeger NJ, Holleman F, van Eck-Smit BL, Bennink RJ, Verberne HJ. ¹⁸F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study. Eur J Nucl Med Mol Imaging 2015;42:1408-13. [PMID: 25655485 DOI: 10.1007/s00259-015-3010-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
111 Yakar A, Yakar F, Sezer M, Bayram M, Erdoğan EB, Özkan D, Özçelik HK, Tabak L. Use of PET-CT for the assessment of treatment results in patients with sarcoidosis. Wien Klin Wochenschr 2015;127:274-82. [DOI: 10.1007/s00508-014-0647-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
112 Lei W, Zeng DX, Chen T, Jiang JH, Wang CG, Zhu YH, Huang JA. FDG PET-CT combined with TBNA for the diagnosis of atypical relapsing polychondritis: report of 2 cases and a literature review. J Thorac Dis 2014;6:1285-92. [PMID: 25276371 DOI: 10.3978/j.issn.2072-1439.2014.08.21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
113 Hess S, Hansson SH, Pedersen KT, Basu S, Høilund-carlsen PF. FDG-PET/CT in Infectious and Inflammatory Diseases. PET Clinics 2014;9:497-519. [DOI: 10.1016/j.cpet.2014.07.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
114 Saleem BR, Pol RA, Slart RH, Reijnen MM, Zeebregts CJ. 18F-Fluorodeoxyglucose positron emission tomography/CT scanning in diagnosing vascular prosthetic graft infection. Biomed Res Int 2014;2014:471971. [PMID: 25210712 DOI: 10.1155/2014/471971] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
115 Choe H, Inaba Y, Kobayashi N, Miyamae Y, Ike H, Yukizawa Y, Saito T. (18)F-fluorodeoxy glucose and (18)F fluoride PET for detection of inflammation focus in periprosthetic hip joint infection cases. Mod Rheumatol 2015;25:322-4. [PMID: 25036230 DOI: 10.3109/14397595.2014.931505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Leccisotti L, Perna F, Lago M, Leo M, Stefanelli A, Calcagni ML, Pelargonio G, Narducci ML, Bencardino G, Bellocci F, Giordano A. Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging. J Nucl Cardiol 2014;21:622-32. [DOI: 10.1007/s12350-014-9896-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]